Skip to main content

Barinthus Biotherapeutics plc.

BRNSDelisted Sep 9, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001828185

Barinthus Biotherapeutics plc. was delisted on Sep 9, 2026; its insiders filed their last Form 4 on Sep 11, 2026; 15 institutions reported holding it in 13F filings for Q2 2026, worth $7.84M in total; no superinvestor held it.

13F holders, Q2 2021

Institutional positions in Barinthus Biotherapeutics plc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
19
+19 vs. Q1 2021
Shares held
4.63M
+4.63M vs. Q1 2021
Total value
$76.8M
+$76.8M vs. Q1 2021
New holders
19
0 more added
Sold out
0
0 more reduced

Compare with Q1 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting BRNS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2021: 19 institutions
Q1 2021: 0 institutionsQ2 2021: 19 institutionsQ3 2021: 15 institutionsQ4 2021: 15 institutionsQ1 2022: 12 institutionsQ2 2022: 13 institutionsQ3 2022: 11 institutionsQ4 2022: 15 institutionsQ1 2023: 13 institutionsQ2 2023: 15 institutionsQ3 2023: 16 institutionsQ4 2023: 15 institutionsQ1 2024: 15 institutionsQ2 2024: 18 institutionsQ3 2024: 19 institutionsQ4 2024: 16 institutionsQ1 2025: 15 institutionsQ2 2025: 14 institutionsQ3 2025: 15 institutionsQ4 2025: 13 institutionsQ1 2026: 14 institutionsQ2 2026: 15 institutions
Value heldQ2 2021: $76.8M
Q1 2021: $0Q2 2021: $76.8MQ3 2021: $77.6MQ4 2021: $54.3MQ1 2022: $23.8MQ2 2022: $27.5MQ3 2022: $31.2MQ4 2022: $22.2MQ1 2023: $21.6MQ2 2023: $20.0MQ3 2023: $29.5MQ4 2023: $36.5MQ1 2024: $21.3MQ2 2024: $11.8MQ3 2024: $10.7MQ4 2024: $10.3MQ1 2025: $9.15MQ2 2025: $9.02MQ3 2025: $10.4MQ4 2025: $6.10MQ1 2026: $7.89MQ2 2026: $7.84M
Institutions holding BRNS and their total value by quarter
QuarterHoldersValue
Q2 202615$7.84M
Q1 202614$7.89M
Q4 202513$6.10M
Q3 202515$10.4M
Q2 202514$9.02M
Q1 202515$9.15M
Q4 202416$10.3M
Q3 202419$10.7M
Q2 202418$11.8M
Q1 202415$21.3M
Q4 202315$36.5M
Q3 202316$29.5M
Q2 202315$20.0M
Q1 202313$21.6M
Q4 202215$22.2M
Q3 202211$31.2M
Q2 202213$27.5M
Q1 202212$23.8M
Q4 202115$54.3M
Q3 202115$77.6M
Q2 202119$76.8M
Q1 20210$0

Institutions, Q2 2021

Shares, value and share of portfolio for each institution holding Barinthus Biotherapeutics plc.; share changes are against Q1 2021.

Institutions holding BRNS in Q2 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Alphabet Inc.1,704,444$28.6M0.58%+1,704,444New
M&G Investment Management Ltd1,088,597$18.5M0.10%+1,088,597New
DC Funds, LP642,204$10.8M51.19%+642,204New
Tudor Investment Corp Et Al420,319$6.01M0.12%+420,319New
Hudson Bay Capital Management LP189,301$3.10M0.04%+189,301New
Monashee Investment Management LLC132,184$2.22M0.27%+132,184New
Millennium Management LLC130,137$2.18M0.00%+130,137New
BlackRock Inc.49,927$839.0K0.00%+49,927New
Caas Capital Management LP50,000$839.0K0.04%+50,000New
Ipswich Investment Management Co., Inc.43,275$726.0K0.19%+43,275New
Vontobel Holding Ltd.40,000$671.0K0.01%+40,000New
Arena Capital Advisors, LLC- CA30,698$515.0K0.04%+30,698New
Brookfield Asset Management Inc.25,000$420.0K0.00%+25,000New
Squarepoint Ops LLC25,000$420.0K0.00%+25,000New
Morgan Stanley16,881$284.0K0.00%+16,881New
Cubist Systematic Strategies, LLC11,562$194.0K0.00%+11,562New
Capstone Investment Advisors, LLC10,000$168.0K0.00%+10,000New
Ghisallo Capital Management LLC10,000$168.0K0.01%+10,000New
ETF Managers Group, LLC10,113$145.0K0.00%+10,113New